These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 33154372)

  • 21. Medical microrobots in reproductive medicine from the bench to the clinic.
    Nauber R; Goudu SR; Goeckenjan M; Bornhäuser M; Ribeiro C; Medina-Sánchez M
    Nat Commun; 2023 Feb; 14(1):728. PubMed ID: 36759511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopy-assisted magnetic navigation of biohybrid soft microrobots with rapid endoluminal delivery and imaging.
    Wang B; Chan KF; Yuan K; Wang Q; Xia X; Yang L; Ko H; Wang YJ; Sung JJY; Chiu PWY; Zhang L
    Sci Robot; 2021 Mar; 6(52):. PubMed ID: 34043547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albumin-Based Nanodevices as Drug Carriers.
    Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
    Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomedicine-based adjuvant therapy: a promising solution for lung cancer.
    Xu Y; Hsu JC; Xu L; Chen W; Cai W; Wang K
    J Nanobiotechnology; 2023 Jul; 21(1):211. PubMed ID: 37415158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application.
    Rizwanullah M; Ahmad MZ; Garg A; Ahmad J
    Biochim Biophys Acta Gen Subj; 2021 Sep; 1865(9):129936. PubMed ID: 34058266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in targeted nanomedicine as promising antitumor therapeutics.
    Hejmady S; Pradhan R; Alexander A; Agrawal M; Singhvi G; Gorain B; Tiwari S; Kesharwani P; Dubey SK
    Drug Discov Today; 2020 Dec; 25(12):2227-2244. PubMed ID: 33011342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects.
    Adebowale AS; Choonara YE; Kumar P; du Toit LC; Pillay V
    Curr Pharm Des; 2015; 21(22):3167-80. PubMed ID: 26027569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake.
    Jin Q; Deng Y; Chen X; Ji J
    ACS Nano; 2019 Feb; 13(2):954-977. PubMed ID: 30681834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Nanomedicines for Cancer Therapy, From Basics to Clinical Trials.
    Eskandari Z; Bahadori F; Celik B; Onyuksel H
    J Pharm Pharm Sci; 2020; 23(1):132-157. PubMed ID: 32369437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules.
    Holgado MA; Martin-Banderas L; Alvarez-Fuentes J; Fernandez-Arevalo M; Arias JL
    Curr Med Chem; 2012; 19(19):3188-95. PubMed ID: 22612702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
    Wicki A; Witzigmann D; Balasubramanian V; Huwyler J
    J Control Release; 2015 Feb; 200():138-57. PubMed ID: 25545217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smart Materials for Microrobots.
    Soto F; Karshalev E; Zhang F; Esteban Fernandez de Avila B; Nourhani A; Wang J
    Chem Rev; 2022 Mar; 122(5):5365-5403. PubMed ID: 33522238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth.
    Moghimi SM
    J Control Release; 2014 Sep; 190():556-62. PubMed ID: 24746624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted nanoparticle-based drug delivery and diagnosis.
    Emerich DF; Thanos CG
    J Drug Target; 2007 Apr; 15(3):163-83. PubMed ID: 17454354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicinal chemistry and nanomedicine for reproductive cancer therapeutics.
    Majumdar D; Singhal S
    Front Biosci (Elite Ed); 2012 Jan; 4(6):2029-44. PubMed ID: 22202018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.